2.1 C
Munich
Friday, April 19, 2024

ImmuCell to delay resubmission of FDA application for Re-Tain (ICCC)

Must read

- Advertisement -


Group of cows together gathering in a field, happy and joyful and a blue cloudy sky.

Clara Bastian

ImmuCell (NASDAQ:ICCC) said it is delaying resubmission of its market application to the US Food and Drug Administration for its dairy cattle medication Re-Tain by one month in order to better prepare for a re-inspection of its manufacturing facilities.

The

- Advertisement -



Source link

- Advertisement -

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article